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The  native  stem  cell  niche  is  a dynamic  and  complex  microenvironment.  Recapitulating  this  niche  is  a
critical  focus  within  the  ﬁelds  of stem  cell  biology,  tissue  engineering,  and  regenerative  medicine  and
requires  the  development  of  well-deﬁned,  tunable  materials.  Recent  biomaterial  design  strategies  seek
to  create  engineered  matrices  that interact  with  cells  at the  molecular  scale  and  allow  on-demand,  cell-
triggered  matrix  modiﬁcations.  Peptide  and  protein  engineering  can  accomplish  these  goals  through
the  molecular-level  design  of  bioinductive  and  bioresponsive  materials.  This  brief review focuses  on
engineered  peptide  and  protein  materials  suitable  for  use  as  in vitro  neural  stem  cell  niche  mimics  and
in  vivo  central  nervous  system  repair.  A key  hallmark  of  these  materials  is  the  immense  design  freedom  totem  cell niche
xtracellular matrix
specify  the  exact  amino  acid  sequence  leading  to  multi-functional  bulk  materials  with  tunable  properties.
These  advanced  materials  are  engineered  using  rational  design  strategies  to recapitulate  key  aspects  of
the  native  neural  stem  cell niche.  The  resulting  materials  often  combine  the  advantages  of  biological
matrices  with  the  engineering  control  of  synthetic  polymers.  Future  design  strategies  are  expected  to
endow  these  materials  with  multiple  layers  of bi-directional  feedback  between  the  cell and  the  matrix,
which  will  lead  to  more  advanced  mimics  of  the  highly  dynamic  neural  stem  cell  niche.© 2012 Elsevier Ireland Ltd. 
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. The neural stem cell niche: a complex and dynamic
icroenvironment
The  native neural stem cell niche is still largely unknown and
their immediate microenvironment is still a poorly deﬁned idea.
For neural stem cells (NSCs) speciﬁcally, it is proposed that they
are highly concentrated around blood vessels where they reside
in close contact with both endothelial cells (ECs) and astrocytes
Open access under CC BY-NC-ND license.ighly transient. While certain areas of the body are known to con-
ain stem cells, and within the adult central nervous system (CNS)
e are aware of neurogenic regions such as the subventricular zone
20] and dentate gyrus [27], the exact contacts these cells make and
∗ Corresponding author. Tel.: +1 650 723 3763; fax: +1 650 498 5596.
E-mail  addresses: klampe@stanford.edu (K.J. Lampe), heilshorn@stanford.edu
S.C.  Heilshorn).
304-3940 © 2012 Elsevier Ireland Ltd. 
oi:10.1016/j.neulet.2012.01.042
Open access under CC BY-NC-ND license.[90]. Both ECs and astrocytes produce molecules important to NSC
self-renewal and differentiation [74,71]. Adding further complex-
ity, the presence or absence of mature neurons can inﬂuence the
fate of new NSCs through a feedback loop [19].
The NSC niche, like all tissues, is a constantly changing microen-
vironment with many factors at play. Soluble factors including
cytokines, neurotrophic or growth factors, and differentiation cues
are constantly synthesized, secreted, transported, and depleted. In
addition, these diffusible, soluble factors may  temporarily bind to
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omponents of the extracellular matrix (ECM) such as hyaluronin
nd laminin, thus further modifying the niche. Several components
f the ECM present cell-adhesion ligands in different conformations
nd densities. The density of the matrix itself affects a cell’s ability to
igrate, and matrix stiffness has been shown to impact the differ-
ntiation of NSCs [48,64,2]. The ECM is constantly being remodeled
y NSC neighbors such as glial cells and capillary-lining ECs through
atrix synthesis and degradation. Furthermore, the location of cells
ithin these niches impacts their access to molecules even as small
s oxygen. Deep tissue may  be considered hypoxic in comparison
o other tissues, and oxygen tension is a critical cue for stem cell
aintenance and differentiation [58]. These dynamic niche pro-
esses create an environment in which cells must constantly sense
nd respond in real time. This series of dynamic feedback is hypoth-
sized to be a critical ingredient to modulate NSC fate.
.  Engineering artiﬁcial neural stem cell niches
Recapitulating the stem cell niche is a critical goal of tissue
ngineers and biologists alike. Ideally, an engineered niche would
nclude both spatial organization and dynamic modulation of cells,
oluble factors, and matrix. While biomaterials technologies are
eing developed to address these needs [51], currently available
atrices often lack this level of complexity. Nonetheless, even
impliﬁed models of the NSC niche are invaluable as reduction-
st models of cell–microenvironment interactions and as potential
caffolds for regenerative CNS therapies. This reductionist strategy
sserts that not all aspects of the in vivo niche are required to cre-
te an in vitro mimic  that guides speciﬁc cell responses, even while
cknowledging that all of these cues are present and likely affecting
ells in vivo. In order to study speciﬁc features of the NSC envi-
onment, many groups have attempted to engineer materials that
llow isolation of individual variables, such as stiffness, without
arying others, such as the density of ligands for integrin binding.
or example, materials with tunable mechanical properties have
een engineered to mediate NSC self-renewal and differentiation
s well as astrocytic activation and glial scarring [48,64,2]. Such
aterials can be complex in their design and structure, but also
legantly simple.
In  this review, we discuss engineered peptide and protein bio-
aterials that are designed at the molecular level to mimic  critical
spects of the NSC niche. We  explain the rationale for using pep-
ide and protein design to create NSC niche mimics, illustrate
esign strategies to create controlled materials with tunable prop-
rties, and highlight recent advances in translating these materials
o regenerative therapies. We  conclude with a discussion of cur-
ent efforts and future opportunities to move beyond reductionist
pproaches and to increase the complexity of peptide-engineered
aterials. In particular, efforts at making these materials more bio-
esponsive and bio-inductive by introducing dynamic feedback into
he system will be instrumental in furthering fundamental studies
nd therapeutic applications of cell–niche interactions.
. Designer peptides and proteins as ECM mimics
Engineered peptide and protein materials provide the advan-
ages of a biological matrix with the control of a synthetic polymer.
hey could be considered a merger of the two, retaining the bioac-
ivity of harvested protein materials, like collagen and ﬁbrin, with
he control and tunability of synthetic, chemically deﬁned materi-
ls, such as poly(ethylene glycol) (PEG) and poly(lactic-co-glycolic
cid)  (PLGA).
Most cell–matrix studies to date have utilized native ECM
olecules harvested from tissues, e.g., laminin, ﬁbrin, collagen,
nd Matrigel. These bioactive materials are often highly cellce Letters 519 (2012) 138– 146 139
adhesive;  however, they suffer from large batch-to-batch varia-
tions in chemical makeup and mechanical properties. Although
these materials can be used as either two-dimensional (2D) coat-
ings or 3D hydrogels, they are ill suited for controlled studies of
cell–matrix interactions. For example, decreasing the stiffness of
a collagen gel can be achieved by decreasing the collagen con-
centration; however this also results in a decrease of adhesive
ligand concentration and an increase in diffusivity, thus confound-
ing the anticipated effects with additional variables. Furthermore,
harvested materials, such as Matrigel, are often a mixture of multi-
ple, ill-deﬁned components. As a consequence, Matrigel is unlikely
to meet FDA criteria for clinical applications and is a non-ideal
culture choice for cells with clinical potential.
Engineered peptide and protein materials are uniquely posi-
tioned to meet the desire for a bioactive scaffold that is completely
deﬁned and tailorable. Designing these proteins from the molecule
up gives users a great deal of ﬂexibility and creativity while also
enforcing strict reproducibility. Peptide and protein material design
can not only provide speciﬁcity in structure, cellular interaction,
neighboring protein binding and dynamic events, but can also
create additional functionality such as reaching adhesive site den-
sities not possible with native materials [73]. Such molecular-level
design leads to new strategies and affords greater control over
resulting matrices than using harvested or synthetic materials. Both
peptide and protein engineered materials have a polymer backbone
made of amino acid sequences that are inherently bioactive and
bioresorbable. These sequences can be derived from nature or iden-
tiﬁed through computational design or high-throughput screening
to achieve functionalities beyond what are capable with native
materials. Typically these bioactive sequences are utilized as func-
tional building blocks in the modular design of engineered peptide
and protein materials (Fig. 1). This mix-and-match strategy enables
enormous creativity in the design of matrices with tunable mechan-
ical, chemical, and biological properties. In the next two sections,
we discuss several examples of this bio-inspired design strategy
to create NSC niche mimics from engineered peptide and protein
materials.
4. Molecular-level design of engineered peptide materials
Synthetic approaches for peptide materials, i.e., short chains of
amino acids, are quite different from protein materials, i.e., long
chains of amino acids; however, both strategies allow researchers
the unique ability to program the exact monomer sequence
within the biopolymer. Utilization of synthetic peptides as a
component within engineered biomaterials is now a standard
technique. For example, peptides have been grafted to a variety
of synthetic polymers to endow the material with cell-adhesive,
enzymatically degradable, and growth factor-binding properties
[89,17,66,68,37,39]. Common amino acid sequences employed to
replicate the in vivo niche include cell-adhesive domains derived
from collagen (DGEA, RGD), laminin (IKVAV, RGD, YIGSR), and
ﬁbronectin (REDV, RGDS).
More recently, groups have started using peptides not only
as biofunctional modules that decorate synthetic polymers, but
also as structural components that dictate the underlying network
of the matrix. These structural components are often based on
totally new peptide domains conceived through rational design
based on predictable amino acid interactions. As with all polymeric
materials, molecular interactions dictate the nanoscale architec-
ture and the resulting bulk material properties. Through choice
of amino acid monomer sequence, the peptides can predictably
fold into secondary structures, such as -helices and -sheets,
that further self-assemble through complementary electrostatic
and/or hydrophilic/hydrophobic interactions. As a consequence,
140 K.J. Lampe, S.C. Heilshorn / Neuroscience Letters 519 (2012) 138– 146
Fig. 1. Schematic of design strategies (left) and assembled structures (right) for selected engineered peptide and protein materials. (A) Four repeats of the RADA amino acid
sequence  form peptides that self-assemble based on electrostatic and hydrophilic/hydrophobic interactions to form a 3D hydrogel [57], copyright 2006, with permission
from Elsevier. (B) Peptide amphiphiles self-assemble to align their hydrophilic, cell-adhesive IKVAV sequences and their hydrophobic alkyl tails to create long nanoﬁbers that
branch  and entangle into a 3D network [73], reprinted with permission from AAAS. (C) Resilin-like polypeptides have a modular design that incorporates the highly resilient
resilin structural block with domains that enable cell binding, proteolytic degradation, and protein/polysaccharide binding. The resilin-like domains include amino acids
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ormed  from two recombinant engineered proteins incorporating WW and polypro
.T.S. Wong Po Foo, J.S. Lee, W.  Mulyasasmita, A. Parisi-Amon, S.C. Heilshorn and Na
hese peptides are programmed to organize into hierarchical forms
ike tubes, ﬁbers, or micelles by controlling the processing con-
itions during self-assembly [16]. Microscopic structures such as
bers are a hallmark of native ECM, but have been difﬁcult to
eproduce with synthetic materials, which are typically amorphous
ydrogels. In contrast, peptide engineered materials are commonly
haracterized by ﬁbrous strands, providing a simple method to
eplicate this key aspect of ECM structure [16,35,94,59].
Typically, peptide hydrogels created through rational design are
rogrammed to self-assemble into ﬁbrous hydrogels under phys-
ological conditions without the need for chemical crosslinkers.
ften the individual peptide units are amphiphilic; they contain
wo distinct regions that are hydrophilic and hydrophobic. Under
peciﬁc temperature, pH, and salt conditions, the hydrophobic
omains self-associate to exclude water leaving the hydrophilic
omains exposed on the surface of a ﬁbril-like strand. As an exam-
le, peptide amphiphiles that utilize an increasingly hydrophobic
equence of four alanines, three glycines, and 16 alkyl groups have
een designed to display hydrophilic, cell-adhesive IKVAV peptides
Fig. 1B) [36]. In aqueous conditions at pH 7.4, the molecules orga-
ize to form transparent 3D hydrogels with a composition of only
.5 wt% matrix material, the remainder being aqueous cell culture
edium. As a 3D culture matrix, these hydrogels support encapsu-
ated neural progenitor cell (NPC) growth and differentiation into
eurons at higher efﬁciencies than standard laminin-coated tissue
ulture plates [73].Another  example of amphiphilic directed assembly is a
00-amino-acid-long peptide family designed with hydrophilic
olyelectrolyte segments and hydrophobic helical domains [59].
ermed diblock copolypeptide hydrogels (DCH), the moleculesl Society of Chemistry. (D) Mixing-induced, two-component hydrogels (MITCH) are
omains that hetero-assemble to form a cell-adhesive, 3D hydrogel [25], copyright
l Academy of Sciences of the United States of America.
self-assemble in aqueous solution to form long ﬁbril nanostructures
that branch and entangle to create a 3D hydrogel network. Through
an iterative design process, the researchers varied the length of the
hydrophobic and hydrophilic segments to develop a fundamental
understanding of the resulting structural properties and to gain
control over hydrogel properties such as stiffness, porosity, and
stability.
Both of these peptide amphiphile hydrogels associate through
non-covalent interactions, thus making them thixotropic, i.e., they
can be shear-thinned into a ﬂowing liquid by applying force.
Upon removal of force, the molecules re-assemble into a hydrogel
network with a characteristic time scale. This opens up the possi-
bility of clinically applying these materials through direct injection,
enabling minimally invasive patient delivery.
Perhaps the most familiar peptide hydrogel is PuraMatrixTM,
commercially available since 2001. Also called self-assembling pep-
tide nanoﬁber scaffolds (SAPNS) and RADA peptides based on their
repeating amino acid sequence, they too form nanostructured ﬁb-
rillar hydrogels under physiological salt conditions [94]. The base
of this class of peptides is a 16 amino acid sequence, RADA repeated
four times end to end (Fig. 1A). RADA-based hydrogels form through
ionic bonding between arginine (R) and aspartic acid (D) monomers
on neighboring -sheet molecules and through hydrophic inter-
actions between the interspersed alanine (A) sites. The original
PuraMatrix, consisting of the RADA 16-mer, does not contain any
biologically active domains but is conducive to neuronal growth,
synapse formation, and drug delivery [57,40]. Proliferative NPCs
(BrdU- and nestin-positive) grew out of an organotypic hippocam-
pal slice culture and into the adjacent RADA peptide matrix
[69]. Human fetal NSCs also proliferated and underwent induced
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euronal differentiation when cultured in 3D RADA hydrogels [83].
ecent modiﬁcations to this 16-mer peptide have expanded the
ibrary with bioactive sequences. In one example, a bone marrow
oming peptide (BMHP1) was fused to the RADA sequence [28].
nterestingly, insertion of a short spacer between the bioactive
equence and the structural segment improved hydrogel stabil-
ty and exposure of the bioactive motif, leading to greater NSC
dhesion [79]. RADA peptides have also been fused with the
aminin-derived IKVAV domain, resulting in increased NSC prolif-
ration and more efﬁcient neuronal differentiation [95].
Another  peptide material that self-assembles via the -sheet
otif is the MAX  family of peptides [32,45]. These amphiphilic
olecules fold into two -strands connected by a tetrapep-
ide -hairpin turn. Through alternating lysine and valine amino
cids, the resulting folded structure presents separate hydrophilic
nd hydrophobic faces enabling further assembly into a ﬁbrillar,
upramolecular structure. Through careful selection of the amino
cid primary sequence in these 20-mer peptides, the kinetics of
ierarchical self-assembly can be tuned. For example, replacement
f one lysine residue in the MAX1 peptide with glutamic acid
n the MAX8 peptide enables much faster assembly and a stiffer
esultant hydrogel [32]. These materials have been well charac-
erized for their drug release properties [7,8]. Mesenchymal stem
ells demonstrated good viability upon encapsulation in MAX8 and
fter shear-thinning through a syringe needle [32]. Furthermore,
ecent in vitro studies demonstrated a lack of macrophage activa-
ion, encouraging future in vivo exploration of the MAX  family of
eptides for drug and cell delivery applications [33].
.  Molecular-level design of engineered protein materials
Similar  to peptide-engineered materials, ECM-mimetic proteins
re also created through rational design, with modular peptide
nits fused together to form a multi-functional protein chain. While
eptide materials are typically produced using synthetic chem-
stry methods, engineered proteins are more commonly produced
sing recombinant technology for large-scale production [10,11].
y employing a cell’s molecular machinery, researchers can pro-
uce high ﬁdelity protein polymers with speciﬁed amino acid
ontent according to the pre-programmed DNA code.
One  example of this strategy is the recombinant production of
ollagen based on a native human sequence [92]. These biopoly-
ers address the need for deﬁned bioactive polymers, avoiding
otential contaminants and the potential immunogenicity of pro-
eins harvested from xenogenic tissue. This product has been
xplored primarily for bone, cartilage, and skin applications due to
ollagen’s prevalence in those native tissues. In addition, recombi-
ant collagen can deliver protein drugs via controlled release [81].
imilarly, recombinant silk proteins have been fashioned into drug
elivery particles [46] and used for artiﬁcial ECM because of their
emarkable mechanical strength [42]. These materials address the
eed for deﬁned, controllable biopolymers by attempting to explic-
tly reproduce native amino acid sequences.
To take greater advantage of the recombinant protein engineer-
ng strategy, many ECM-mimetic proteins utilize different types of
eptide domains that confer structural, bioinstructive, and biore-
ponsive properties into the biomaterial. These modules can be
ixed, matched, and repeated multiple times within a full-length
rotein to create a multifunctional material with several desired
haracteristics. A common goal for niche-mimic applications is a
aterial with the structural integrity to maintain encapsulatedtem cells in a 3D environment. Sequences inspired from natural
aterials such as silk [4], elastin [18], and resilin [22] are com-
only chosen for these applications, as each module has a unique
ombination of strength, elasticity, and resilience (the ability toce Letters 519 (2012) 138– 146 141
recover  after deformation under stress). While only elastin is native
to the mammalian body, silk and resilin have unique strength and
resilience properties, respectively, and all three have served as ele-
ments of successful cell scaffolds [4,77,6,41].
Along with these structural building blocks, other modules
can instill a host of additional functionalities into the protein.
In the creation of NSC niche mimics, well-known cell-adhesive
domains RGD, IKVAV, and YIGSR amino acid sequences are fre-
quently integrated into the material. Another type of commonly
used biofunctional domain is preotolytically degradable sequences
that enable cell-triggered degradation of the material via matrix
metalloproteinases (MMPs) or other protease enzymes. Varying
the amino acid sequence in the protease degradation site will
control which enzymes trigger proteolysis, and hence may  con-
fer cell-speciﬁcity in the material [55]. Further modiﬁcation of
the sequence can alter the kinetics of the target enzyme, lead-
ing to biomaterials with widely tunable degradation properties
[77]. As an example, a family of elastin-like proteins has been
created with both interchangeable cell-adhesive domains and
enzyme-degradable domains. By mixing cell-adhesive proteins
with a non-adhesive elastin-like variant, the adhesion site den-
sity can be controlled without modifying protein concentration or
cross-linking, resulting in tunable cell adhesivity and neurite exten-
sion [77]. Further demonstrating their utility in creating stem cell
niches, elastin-like proteins also have been engineered with Notch
receptor ligands [50]. Signaling through the Notch pathway is crit-
ical during tissue development and plays a role in gliogenesis and
neurite extension [56,70,26]. Having manipulatable control over
this pathway via the immediate cellular microenvironment may
help provide understanding of both the NSC niche and nervous
system repair.
One  advantage of protein design is the ability to incorporate
multiple functionalities into a signal molecule. One speciﬁc resilin
polypeptide has been engineered with a cell-adhesive RGD peptide,
an MMP-cleavable sequence to enable proteolytic degradation,
and a heparin-binding domain for non-covalent attachment and
release of growth factors (Fig. 1C) [13]. The tight control over
the amino acid code can be used to modify any sequence to
alter protein folding, improve yields, or simply make single amino
acid substitutions. Individual amino acids such as lysine, tyro-
sine, or phenylalanine [77,13] can be edited in for post-production
chemical modiﬁcations. This may  include the addition of pendant
chemical functionalities for drug delivery, or they may  serve as sites
for protein cross-linking and matrix formation.
While many engineered proteins are processed into hydrogels
through chemical cross-linking, a variety of other strategies can
also be utilized. For example, electrospinning [61], self-assembly
[54], and photo-crosslinking [12] can lead to formation of a bulk
material. A recently described hydrogel strategy involves the sim-
ple mixing of two different multi-domain proteins, which is termed
Mixing-Induced Two-Component Hydrogel (MITCH) [25]. One
protein includes proline-rich domains separated by hydrophilic
spaces with cell-adhesive RGD sequences dispersed throughout
(Fig. 1D). The second protein consists of WW domains separated
by hydrophilic spacers of a different length. Upon mixing, the
proline-rich and WW domains hetero-assemble through hydrogen
bonding to form a networked hydrogel. An entire family of native
and computationally derived WW domains binds to proline-rich
domains, allowing simple tuning of protein-protein binding afﬁnity
and the resulting hydrogel mechanics. One advantage of this gela-
tion strategy is that cells can be encapsulated without exposing
them to chemical crosslinkers or non-physiological temperature,
pH, or ionic strength. Furthermore, the speciﬁc binding between
the proline-rich and WW domains is undisturbed by the presence
of other proteins, enabling the straight-forward encapsulation of
growth factors and other bioactive molecules [25]. MITCH was used
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o create an in vitro artiﬁcial stem cell niche capable of supporting
SC growth and differentiation. This shear-thinning material also
egains its structure after being ejected through a syringe needle,
nabling future use as a stem cell-delivery vehicle in vivo [25].
.  In vivo utilizations and successes using molecularly
esigned materials
Neural  cell transplantation into the injured CNS is hindered by
ow post-transplantation cell viability [75,1,9]. In several transplan-
ation models, improved outcomes have been achieved by using
ioresorptive implant materials [80,98,82,60]. Peptide and protein
aterials may  be ideally suited for these applications, as they can be
uned to mimic  the compositional and mechanical properties of the
urrounding environment, thus promoting integration with host
issue. In the last decade, peptide hydrogels have approached ther-
peutic realization, with notable successes in treating models of a
ut optical track, traumatic brain injury (TBI), and spinal cord injury
SCI) (Fig. 2). In pre-clinical studies, these shear-thinning materials
re often delivered by direct injection through a small-gauge nee-
le, mimicking a minimally invasive clinical procedure. This route
f delivery is particularly attractive for transplantation to the brain,
s a needle can access sensitive deep regions of the brain without
xtensively disrupting the blood–brain barrier.
In an initial biocompatibility study, dipeptide co-block hydro-
els (DCH) composed of poly-lysine and poly-leucine were directly
njected into the caudate putamen of rat brains. Over eight weeks,
CH-injected animals showed minimal astrogliosis, inﬂammation,
nd neuronal toxicity, similar to saline controls (Fig. 2D). Moreover,
he DCH deposit was invaded by glia and a small number of neuro-
lament M-  and tyrosine hydroxylase-positive nerve ﬁbers, indi-
ating functional neurite growth [93]. Another injectable peptide
aterial, the 16-mer RADA peptide, has been injected into the dam-
ged optical track [21] as well as TBI [31] and SCI models [30] with
egenerative success. In the TBI treatment, the peptide nanoﬁbers
educed glial activation and inﬂammation in the surrounding brain
issue, a critical step in limiting the subsequent damage often asso-
iated with this type of brain injury [31]. In the SCI treatment, the
ADA peptide was used to deliver Schwann cells or NPCs into the
orsal column. Both cell types survived and migrated through the
ydrogel matrix (Fig. 2C). In addition, invading host cells and blood
essel ingrowth were observed in the material [30].
As  a demonstration of further molecular-level design, the
ADA peptides were modiﬁed with a bone-marrow homing motif
BMHP1) that affects adhesion and differentiation of multiple stem
ell types [14]. The hydrogel was injected 24 h after a contusion
impactor) SCI injury. Compared to non-treated and saline controls,
he scaffold increased cellular inﬁltration, axon regeneration, and
ative ECM deposition including laminin and collagen IV. The Basso,
eattie, and Bresnahan (BBB) score, a common rating used to assess
ind limb locomotor skills after SCI, demonstrated a slight, but sta-
istically signiﬁcant improvement in locomotor function relative to
ontrols at eight weeks.
Further  work combined this peptide gel with macroscopically
tructured tubes to physically orient regeneration longitudinally
long the spinal cord [29]. In a unique surgical approach that mim-
cs therapeutic intervention long after an injury, scar tissue was
emoved four weeks after the SCI. The resulting cyst was ﬁlled
ith PLGA/PCL conduits ﬁlled either with saline, the RADA-BMHP1
ydrogel alone, or the hydrogel with brain-derived and ciliary
eurotrophic factors to support neuronal survival and outgrowth,
ascular endothelial growth factor (VEGF) to promote angiogene-
is, and chondroitinase ABC to promote remodeling of the glial scar.
ver six months, the implantation site was remodeled with inﬁl-
rating astrocytes, oligodendrocytes, endothelial cells, and axonce Letters 519 (2012) 138– 146
ﬁbers  with particularly high densities of neuronal ﬁbers localized
within the peptide-ﬁlled conduits. Superior function was  shown
in the treated groups by BBB and electrophysiology tests. Further-
more, nerve growth was  continuous through the cyst and crossed
both the rostral and caudal interfaces, indicating directed neu-
ral regeneration (Fig. 2B). While this directional regeneration is
likely a consequence of the spatial orientation of the conduits, the
hydrolytic degradation of the PLGA/PCL may  also play a positive
role. Lactic acid released during PLGA degradation has been shown
to improve NSC survival in the presence of reactive oxygen species
[47,49], an inﬂammatory component of damaged and regenerating
neural tissues.
Shear-thinning IKVAV self-assembling peptide amphiphile
nanoﬁbers also have shown a remarkable ability to reduce
astrogliosis and cell death when injected directly into the dam-
aged spinal cord 24 h after compression injury (Fig. 2A) [85]. A
notable achievement was an increase in the number of myelinating
oligodendrocytes found at the injury site in the treatment group,
with ascending sensory ﬁbers and descending motor ﬁbers pass-
ing through the injury site. Treated animals resulted in greater BBB
behavioral improvement by 9 weeks (Fig. 2A). Again demonstrating
the high level of design control, substituting the IKVAV sequence
with a VEGF peptide led to enhanced blood vessel formation [86],
a critical element of tissue regeneration. Alternatively, heparin-
binding peptide domains can be used to deliver growth factors [76].
Recently these peptide amphiphiles were made into large ﬁbers of
aligned ﬁbrils that can induce cell alignment [96] perhaps allowing
completely peptide-based aligned conduits for SCI.
Similar to engineered peptide materials, the use of tailored,
full-length recombinant proteins for in vivo applications is also
promising. In recent clinical trials, recombinant human collagen
was applied in 10 human subjects with corneal degeneration or
scarring [23]. At two years, the treatment demonstrated endoge-
nous epithelium colonization, recovery of nerve connections, and
restored function [24]. Average nerve density continued to increase
through 24 months, with 9 of 10 patients having nerves at the basal
epithelium by 24 months.
While  harvested silk proteins have been used in peripheral
nerve surgery [42], recombinant silk has been limited by the ability
to accurately reproduce the desired strength characteristics of the
native protein. Recently the recombinant production of full-length
silk was reported, which may  now enable the synthesis of recombi-
nant high tensile strength ﬁbers and eventual application in nerve
regeneration therapies [91]. In a different approach, silk mod-
ules were fused with elastin-like sequences to create a silk-elastin
fusion protein that can be fabricated into any arbitrary shape. The
mechanical strength and durability of the resulting recombinant
protein matrix was designed to mimic  the nucleus pulposus, the
material found in the center of an intervertebral disc [5]. In a human
trial of patients with herniated discs and leg pain unresponsive to
conservative treatment, the engineered protein implant resulted
in signiﬁcant pain improvement with no observed re-herniations
[3]. Elastin-like proteins have also been studied in pre-clinical drug
delivery applications. Controlled drug release from a supramolec-
ular, elastin-like protein assembly was  achieved by adjusting the
amino acid sequence and the total protein molecular weight [53].
These thermo-responsive molecules gelled in vivo and served as a
localized source of model drug to nearby dorsal root ganglion with
a seven-fold greater half-life compared to soluble protein alone.
7.  Future perspective: designing bi-directional, cell–matrix
feedback into niche mimics
The  dynamic “give and take” of cell–ECM interactions is an
increasingly recognized critical component of stem cell function.
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Fig. 2. Selected in vitro and in vivo data demonstrating application of engineered peptide and protein materials in neural stem cell culture and CNS regeneration. (A) IKVAV
peptide amphiphiles (PA) promote functional improvement after SCI. IKVAV PA-treated animals showed statistically greater improvement in mean locomotor BBB scores
after  5 weeks. The hydrogel also attenuated astrogliosis, with less GFAP scarring observed at 5 and 11 weeks [85], with permission from the Society for Neuroscience. (B) Four
weeks  after SCI, scar tissue was replaced with degradable conduits ﬁlled with a modiﬁed RADA peptide. A longitudinal reconstruction of NF200-postive ﬁbers shown in red
indicates  aligned neuronal growth through the hydrogel-ﬁlled conduit and crossing into both the rostral and the caudal host tissue [29]. Copyright (2011) American Chemical
Society. (C) RADA peptide scaffolds support in vitro culture of GFP-positive Schwann cells and neural precursor cells (NPCs) for up to 4 weeks. Schwann cells continue to label
for  p75, and NPCs remain primarily nestin-positive, but also differentiate into neurons, astrocytes, and oligodendrocytes (not shown) [30], copyright 2007, with permission
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re observed around the needle track (top) and at the tissue interface with the DCH
tem cells and their surrounding support cells constantly remodel,
egrade, and replace the niche matrix, which in turn results in
ltered stem cell behavior. As a mimic  of this dynamic inter-
lay, several biomaterial strategies have been developed to enable
riggered matrix modiﬁcation. One of the most common design
lements for this purpose is the inclusion of proteolytic degrada-
ion sites. Depending on the location of the cleavable target sites,
his strategy has been used to accomplish matrix softening [77],
elease of tethered bioactive factors [66,65], and selective degra-
ation of internal channels [78]. These examples demonstrate howastrocytosis comparable to saline up to 8 weeks. GFAP-labeled reactive astrocytes
sit (bottom) [93], copyright 2009, with permission from Elsevier.
cell-secreted  enzymes can be harnessed to initiate matrix modiﬁ-
cations “on demand”.
In  the future, it is expected that several individual cell–matrix
interactions will be layered together in a single engineered mate-
rial to create dynamic, bi-directional feedback systems (Fig. 3).
For example, as stem cells proliferate in response to a growth-
permissive matrix doped with time-released growth factors, they
may  secrete an accumulating amount of a speciﬁc protease.
This stem-cell-speciﬁc protease may  then trigger a modiﬁca-
tion of the material such as matrix softening. In response to
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Fig. 3. Future engineered stem cell niches may  be designed to mimic  the dynamic
native  niche environment through incorporation of bi-directional feedback between
encapsulated cells and their matrix. In one potential realization, (1) stem cells ini-
tially adhere to a matrix that (2) releases factor 1 at a speciﬁc time. (3) Factor 1 could
be a growth factor that leads to stem cell proliferation and the accumulation of pro-
tease 1. (4) Protease 1 degrades speciﬁc regions of the matrix, which may  lead to a
change in stiffness, thus inducing stem cell differentiation. (5) Upon differentiation,
cells  alter their proteome and begin secreting protease 2. (6) Protease 2 triggers the
cleavage of cell binding ligands, (7) thereby inducing cell migration and extension of
processes such as axons and dendrites into the surrounding material. Listed below
are several potential bi-directional response elements that could be designed into
future dynamic matrices.ce Letters 519 (2012) 138– 146
the new microenvironment, the stem cells may  be induced to
follow a speciﬁc differentiation pathway. As the cells begin dif-
ferentiation, their proteome is altered, leading to secretion of a
different set of proteases. This second family of proteases can
then be utilized to trigger a second type of matrix remodel-
ing.
While protease secretion is perhaps the most recognized and
straight-forward route through which cells can remodel an engi-
neered matrix, a variety of cell-responsive elements could be
designed into these materials. For example, cells are known to
remodel the native extracellular matrix through ﬁber bundling
[97], stretching of proteins to reveal hidden “cryptic” domains
and molecules [43,88], and deposition of new proteins and stiff-
ening of the matrix [67]. Each of these native cell behaviors could
be replicated in an engineered polypeptide material. In addition,
polypeptide materials can be designed to respond to a variety of
external stimuli such as pH [72], temperature [53], ion concentra-
tion [84], and exposure to ultraviolet light [38,87,63]. An external
light stimulus was recently utilized to induce material remodeling
of a synthetic polymeric hydrogel [17,44]. Based on several differ-
ent clever design strategies, a common external stimulus (i.e., light
exposure) could be used to open up channels within the hydrogel,
to weaken the mechanical properties of the matrix, or to reduce or
increase the concentration of cell binding ligands within the matrix
[17,44]. Each of these matrix-remodeling processes was  observed
to initiate speciﬁc, distinct cellular responses. These results high-
light the importance of dynamic matrix control when designing
biomimetic materials to interface with cells.
Engineered peptides and proteins are ideal building blocks to
fabricate these dynamic, biomimetic matrices for both in vitro
and in vivo applications. As platforms for in vitro culture, these
materials can be used both to help maintain stem cells in a more
“native-like” environment and to probe mechanistic pathways of
cell–matrix interactions. During prolonged culture, stem cells often
begin to display reduced proliferative capacity and limited differ-
entiation potential, which is hypothesized to be a consequence of
the absence of normal microenvironmental cues [52]. A key aspect
of the native stem cell niche, and hence a critical goal of engineered
niche mimics, is dimensionality. Most cell types, including neural
cells, display markedly different morphology in three-dimensional
versus two-dimensional culture platforms [48,62]. In general, it
is thought that three-dimensional culture materials induce orga-
nization of cytoskeletal structures that more accurately replicate
in vivo cellular phenomena [15,34]. Several engineered peptide
and protein materials have demonstrated success at supporting
the three-dimensional culture of neuronal cell types, encouraging
the further development of these materials as reproducible culture
platforms [73,28,25]. As these materials become dynamic matrices
capable of bi-directional interactions with cells, they will open up
new avenues of stem cell biology research by allowing temporal
control of matrix properties.
Similar  to biomaterials used as culture matrices, biomaterials
used for in vivo applications must be bioactive and should allow
reproducible control of chemical and material properties. In addi-
tion, for clinical application these materials must be minimally
immunogenic and be composed of deﬁned FDA-approvable ingre-
dients. Engineered peptide and protein materials fulﬁll these needs
and enable the development of combination therapies that deliver
matrix, cells, and soluble factors in a single construct [30,29,76]. As
development of these combination therapies continues, materials
must be designed to serve not just as cell- and growth factor-
delivery depots, but as niche mimics that can guide cell fate and
development. Recent in vivo data highlight the combined use of sol-
uble factor delivery from a nanoscale matrix structure to enhance
the regenerative ability of endogenous cells in an SCI model [29].
While several peptide hydrogels form nano-ﬁbrous structures,
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ypically the ﬁbrils are randomly oriented. To overcome this lim-
tation, peptide materials can be combined with novel processing
ethods to produce aligned nano-ﬁbrils that physically guide cell
rowth [96]. Future engineered materials are likely to include addi-
ional levels of molecular-, nano-, and micro-scale design in order
o mimic  the multiple structural length scales observed in native
issue. Peptide and protein materials will further our understanding
f the stem cell niche and allow researchers to control and perturb
ystem elements in a deﬁned, bioactive, and bioresponsive three-
imensional matrix. Furthermore, as strategies to create dynamic
ioactive materials develop, they will be molecularly designed to
eet the evolving requirements of transplanted cells during the
ultiple stages of cell engraftment and tissue regeneration.
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